SCHEMBL8926073

SCHEMBL8926073

COc1ccc([C@H](O)[C@H]2CC(=O)CCN2C(=O)c2cc(C)cc(C)c2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2C Q14957 2/20 0.40
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
ALDH1A1 P00352 3/20 0.38
HSD17B2 P37059 1/20 0.38
RECQL P46063 2/20 0.38
TSHR P16473 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
KDM4E B2RXH2 2/20 0.37
MAPT P10636 2/20 0.37
LHCGR P22888 1/20 0.37
GAA P10253 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2D6 P10635 1/20 0.37
THRB P10828 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
BLM P54132 1/20 0.37
TACR1 P25103 1/20 0.36
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8925866 1.00 GRIN2C (0.40) GRIN2CMEN1KMT2AALDH1A1HSD17B2
SCHEMBL8927584 0.90 HSD17B2 (0.42) GRIN2CMEN1KMT2AHSD17B2TACR1
SCHEMBL8923597 0.90 HSD17B2 (0.42) GRIN2CMEN1KMT2AHSD17B2TACR1
SCHEMBL9565771 0.90 HSD17B2 (0.42) GRIN2CMEN1KMT2AHSD17B2TACR1
SCHEMBL9204527 0.88 TACR1 (0.41) ALDH1A1HSD17B2KDM4ETACR1LMNA
SCHEMBL8939874 0.88 TACR1 (0.41) ALDH1A1HSD17B2KDM4ETACR1LMNA
SCHEMBL8924315 0.87 HSD17B2 (0.36) ALDH1A1HSD17B2SMN1; SMN2GAATACR1
SCHEMBL8925754 0.87 HSD17B2 (0.36) ALDH1A1HSD17B2SMN1; SMN2GAATACR1
SCHEMBL8925221 0.84 MTNR1B (0.38) MEN1KMT2ATSHRGAATACR1
SCHEMBL8925804 0.84 MTNR1B (0.38) MEN1KMT2ATSHRGAATACR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0532456-B1 1-Acylpiperidine derivatives and their use as substance P antagonists CIBA GEIGY AG (CH) 1995-03-29 EP claimed
EP-0532456-A1 1-Acylpiperidine derivatives and their use as substance P antagonists CIBA-GEIGY AG (CH) 1993-03-17 EP claimed
US-5646144-A FOR TREATING DISORDERS IN WHICH SUBSTANCE P PLAYS A PART IN DEVELOPMENT CIBA-GEIGY CORPORATION (US) 1997-07-08 US disclosed
EP-0532456-B1 1-Acylpiperidine derivatives and their use as substance P antagonists CIBA GEIGY AG (CH) 1995-03-29 EP disclosed
US-5310743-A Substance P antagonist CIBA-GEIGY CORP. (US) 1994-05-10 US disclosed